ACELRX PHARMACEUTICALS (ACRX) Covered Calls

ACELRX PHARMACEUTICALS covered calls

You can sell covered calls on ACELRX PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ACRX (prices last updated Fri 4:16 PM ET):

ACELRX PHARMACEUTICALS (ACRX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
3.63 -0.52 3.54 3.55 5.4M - 0.3B
Covered Calls For ACELRX PHARMACEUTICALS (ACRX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 2.5 1.35 2.20 13.6% 171%
Dec 21 2.5 1.40 2.15 16.3% 93.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company that focuses on the development and commercialization of therapies for the treatment of actual pain. Its lead product candidate includes ZalvisoTM intended for the management of moderate-to-severe acute pain in hospitalized adult patients. Zalviso consists of sufentanil sublingual tablets delivered by the Zalviso System, a needle-free, handheld, patient-administered, pain management system. It is designed to address the problems associated with post-operative intravenous patient-controlled analgesia, or IV PCA. AcelRx Pharmaceuticals was founded by Thomas A. Schreck and Pamela P. Palmer on July 13, 2005 and is headquartered in Redwood City, CA.